• 

ISCB releases COVID-19 Section

You can still be part of the Virtual ISMB 2020 Conference. The conference is accepting submissions for COVID-19 Abstracts and Late Posters.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

The COVID-19 pandemic is both severely affecting our lives and impacting our science. ISCB responds to the respective challenges by offering its expertise to the scientific community and empowering scientific networking. The ISCB COVID-19 Section (https://www.iscb.org/covid19) offers four lines of this initiative:

ISCB COVID-19 Statements. Here you find statements on the ongoing pandemic that have been issued by ISCB. ISCB COVID-19 Webinar collection. Here you find webinars specific to the topics of COVID-19 and Sars Cov-2 that are organized by ISCB. Mark your calendars for the first complimentary webinar on May 19! ISCB COVID-19 Science collection. Here you find materials specific to the topics of COVID-19 and Sars Cov-2 that have been submitted by ISCB members. This collection has three subsections for (i) scientific articles, (ii) scientific data sets and, (iii) proposals of community science projects. ISCB Tutorial collection. Here you find tutorials that present basic or advanced computational biology content for biologists and computational biologists in these times of increased digital education activity. The tutorials have been (i) presented at recent ISCB conferences and (ii) suggested by ISCB members.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Call for Submissions If you are a member of ISCB, we encourage you to submit entries to the Science collection and Tutorial collection. Your submission entails a pointer to the science content, a short description of background or purpose (two lines) and lists your name as submitter. Submission will be subjected to a basic check of scope and purpose. You find the relevant submission forms here - https://www.iscb.org/covid19-submissions.

Call for Submissions

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Upcoming Webinar A SARS-CoV-2 protein interaction map reveals targets for drug repurposing By Nevan Krogan May 19, 2020 at 11:00 AM EDT! Efforts to develop antiviral drugs versus COVID-19 or vaccines for its prevention have been hampered by limited knowledge of the molecular details of SARS-CoV-2 infection. This webinar will describe our efforts to address this challenge by expressing 26 of the 29 SARS-CoV-2 proteins in human cells and identifying the human proteins physically associated with each using affinity-purification mass spectrometry. Among 332 high-confidence SARS-CoV-2-human protein-protein interactions, we identified 66 druggable human proteins or host factors targeted by 69 compounds (29 FDA-approved drugs, 12 drugs in clinical trials, and 28 preclinical compounds). Within a subset of these, multiple viral assays identified two sets of pharmacological agents that displayed antiviral activity. Registration is complimentary.

Register Here

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

More Information

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

---

• Prev
• Next